COMMUNIQUÉS West-GlobeNewswire

iTeos publie les résultats financiers de son premier trimestre 2025 et fait le point sur ses activités

29/04/2025 - 23:47

- Données de haut niveau provisoires issues de l’essai GALAXIES Lung-201, et plus de 240 patients attendus au deuxième trimestre 2025 - Données provisoires issues des essais GALAXIES H&N-202 et TIG-006 HNSCC, et [...]

Assemblée Générale mixte du 21 mai 2025 - Modalités de mise à disposition ou de consultation des documents préparatoires

29/04/2025 - 17:40

Communiqué de presse Paris – Le 29 avril 2025 – Les actionnaires d’EUROAPI sont invités à participer à l’Assemblée Générale mixte qui se tiendra le mercredi 21 mai 2025 à 10h30 au 15 bis rue Traversière 75012 Paris. L’ [...]

Combined General Meeting of May 21, 2025 - Availability of preparatory documents

29/04/2025 - 17:40

Press Release Paris – April 29, 2025 – EUROAPI’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday May 21, 2025 at 10:30 a.m. (CET) at 15 bis, rue Traversière 75012 Paris. The [...]

Lirum Therapeutics’ LX-101 New Positive Data Selected for Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting

29/04/2025 - 17:45

New York, NY, April 29, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today that new [...]

EssilorLuxottica: Déclaration de transactions sur actions propres

29/04/2025 - 18:00

Déclaration de transactions sur actions propres Paris, France (29 avril 2025, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 22 avril 2025 au [...]

EssilorLuxottica: Disclosure of transactions in own shares

29/04/2025 - 18:00

Disclosure of transactions in own shares Paris, France (April 29, 2025 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2024, EssilorLuxottica declares that from [...]

PLANT ADVANCED TECHONOLIGES (PAT) : Résultats Annuels 2024

29/04/2025 - 18:01

Vandœuvre-lès-Nancy, le 29 avril 2025 – 18 : 00 (CET) Communiqué de presse Pour diffusion immédiate Résultats Annuels 2024 de la Société PAT Premier résultat d'exploitation positif depuis la création de PAT en 2005 : [...]

Louw Alberts Psychology Practice Rebrands from Talk It Out to Strengthen Identity

29/04/2025 - 18:26

Embracing a New Identity: Louw Alberts Psychology Practice Centurion, Gauteng, April 29, 2025 (GLOBE NEWSWIRE) -- Louw Alberts Psychology Practice, a renowned counselling practice based in Centurion, South Africa, has [...]

NADP Advocates for Greater Access to Care through Dental Coverage

29/04/2025 - 19:00

Association Represents Dental Benefits Industry at Advocacy in Action DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- The National Association of Dental Plans (NADP) demonstrated its strong commitment to expanding access to [...]

Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts

29/04/2025 - 19:48

WARREN, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today informed shareholders about several differences between holding shares in Direct Registration [...]

Best Steroid for Women for Muscle Growth and Fat Loss 2025 - Top Anabolic Steroids for Female Bodybuilders With Before and After Results - CrazyBulk

29/04/2025 - 19:58

New York City, April 29, 2025 (GLOBE NEWSWIRE) -- Best steroids for women for building muscle and losing fat presented by CrazyBulk Are you a female bodybuilder or athlete looking to take your physique to the next level [...]

Mainz Biomed Enters into Technology Partnership with EDX Medical Group

29/04/2025 - 14:01

BERKELEY, Calif. and MAINZ, Germany, April 29, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of [...]

Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call

29/04/2025 - 14:02

DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial [...]

LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients

29/04/2025 - 14:05

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announced plans to offer broad, affordable, and streamlined access to Wegovy ® (semaglutide [...]

Ernexa Therapeutics Presented Promising Data on Innovative Cell Therapy Treatment at AACR Annual Meeting 2025

29/04/2025 - 14:30

Study showed engineered stem cell-derived therapy recruits key immune cells and slows tumor growth, supporting continued development of Ernexa’s advanced cancer pipeline CAMBRIDGE, Mass., April 29, 2025 (GLOBE NEWSWIRE [...]

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025

29/04/2025 - 14:30

BERKELEY HEIGHTS, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and [...]

FYR Enters Know-How Agreement with Mayo Clinic to Collaborate on Blood-Based Biomarker Solutions for Parkinson’s Disease

29/04/2025 - 14:30

Collaboration aims to use FYR’s AI-enabled EV-Omics (EVO) platform to produce dynamic, real-time insights into Parkinson’s disease MISSOULA, Mont., April 29, 2025 (GLOBE NEWSWIRE) -- FYR, a biotechnology company [...]

First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton

29/04/2025 - 14:30

Approval signals important progress in U.S. market expansion as major commercial health insurers begin to follow precedent set with Medicare reimbursement for personal exoskeletons established in 2024 Decision to cover [...]

CytoDyn Leadership Team To Attend ESMO Breast Cancer Meeting in Munich, Germany

29/04/2025 - 14:30

Dr. Jacob Lalezari, CEO, and Dr. Richard Pestell, Lead Consultant in Preclinical and Clinical Oncology, to lead CytoDyn group in attendance VANCOUVER, Washington, April 29, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: [...]